Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.17 USD | -0.21% | -4.81% | +29.60% |
09/05 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
08/05 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.60% | 6.13B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+45.09% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Oppenheimer Raises Revolution Medicines Price Target to $43 From $40, Maintains Outperform Rating